Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9801747 | 0.86 | KEAP1 (0.37) | BCHESIGMAR1 | |
| SCHEMBL9801817 | 0.81 | KEAP1 (0.36) | SIGMAR1 | |
| SCHEMBL9801762 | 0.80 | SIGMAR1 (0.37) | SIGMAR1 | |
| SCHEMBL9801496 | 0.79 | SIGMAR1 (0.40) | SIGMAR1 | |
| SCHEMBL9801740 | 0.78 | KEAP1 (0.36) | SIGMAR1 | |
| SCHEMBL9801737 | 0.77 | SIGMAR1 (0.39) | SIGMAR1 | |
| SCHEMBL9801426 | 0.73 | ALOX15 (0.44) | SIGMAR1 | |
| SCHEMBL9801005 | 0.72 | L3MBTL1 (0.34) | SIGMAR1 | |
| SCHEMBL9801794 | 0.72 | KEAP1 (0.38) | SIGMAR1 | |
| SCHEMBL9801533 | 0.72 | SIGMAR1 (0.41) | SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022133281-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS | CIDARA THERAPEUTICS, INC. (US) | 2022-06-23 | — | — | WO | disclosed |